Literature DB >> 19415358

Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea.

Nabil Al Lawati1, Alan Mulgrew, Rupi Cheema, Stephan vanEeden, Arsalan Butt, John Fleetham, Frank Ryan, Najib Ayas.   

Abstract

PURPOSE: Systemic inflammation is important in the pathogenesis of cardiovascular disease (CVD). We sought to characterize the systemic inflammatory profile associated with obstructive sleep apnea (OSA).
METHODS: Adult patients referred for suspected OSA at the University of British Columbia Hospital Sleep Disorders Program were recruited for our study. Patients using HMG CoA inhibitors or a history of CVD were excluded. Fasting serum samples were obtained the morning after their diagnostic polysomnograms. Samples were tested for the following circulating inflammatory mediators: interferon gamma; interleukins 1B, 6, and 8; intercellular and vascular cell adhesion molecules (sICAM-1 and sVCAM-1); and leptin using a multiplex Luminex System.
RESULTS: There were 176 patients; 68% were male, mean age = 50 +/- (SD) 11 years, mean apnea/hyponea index (AHI) = 22.9 +/- 22/h, mean desaturation (i.e. % of sleep time spent below an oxyhemoglobin saturation of 90%) = 5.4% +/- 15, and mean body mass index (BMI) = 32.2 +/- 8 kg/m(2). In univariate analyses, only leptin, sVCAM-1, and sICAM-1 were significantly associated with indices of OSA severity (i.e. AHI and/or desaturation). In multivariate linear regression analyses that controlled for BMI, gender, age, and current smoking; desaturation persisted as a significant independent predictor for elevated sVCAM-1 and leptin.
CONCLUSIONS: We did not find significant associations between OSA and markers of activated innate immunity (IL-1B, 6, and 8). However, OSA severity was independently associated with serum levels of sVCAM-1 and leptin; these may represent mechanisms involved in the pathogenesis of OSA-related CVD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415358     DOI: 10.1007/s11325-009-0259-1

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  24 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity.

Authors:  Silke Ryan; Geraldine M Nolan; Evelyn Hannigan; Sean Cunningham; Cormac Taylor; Walter T McNicholas
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

3.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

4.  Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome.

Authors:  E Ohga; T Nagase; T Tomita; S Teramoto; T Matsuse; H Katayama; Y Ouchi
Journal:  J Appl Physiol (1985)       Date:  1999-07

5.  Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.

Authors:  Kenji Minoguchi; Takuya Yokoe; Toshiyuki Tazaki; Hideko Minoguchi; Akihiko Tanaka; Naruhito Oda; Shinji Okada; Shin Ohta; Hirokuni Naito; Mitsuru Adachi
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

6.  Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.

Authors:  Rajat Deo; Amit Khera; Darren K McGuire; Sabina A Murphy; Januario de P Meo Neto; David A Morrow; James A de Lemos
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

7.  Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome.

Authors:  Silke Ryan; Cormac T Taylor; Walter T McNicholas
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

8.  Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea.

Authors:  Harald Schäfer; Dirk Pauleit; Thomas Sudhop; Ioanna Gouni-Berthold; Santiago Ewig; Heiner K Berthold
Journal:  Chest       Date:  2002-09       Impact factor: 9.410

9.  Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial.

Authors:  M Kohler; L Ayers; J C T Pepperell; K L Packwood; B Ferry; N Crosthwaite; S Craig; M M Siccoli; R J O Davies; J R Stradling
Journal:  Thorax       Date:  2008-09-11       Impact factor: 9.139

10.  The effect of acute intermittent hypercapnic hypoxia treatment on IL-6, TNF-alpha, and CRP levels in piglets.

Authors:  Charmaine S Tam; Melanie Wong; Kimberley Tam; Leyla Aouad; Karen A Waters
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

View more
  11 in total

Review 1.  The role inflammatory response genes in obstructive sleep apnea syndrome: a review.

Authors:  Francisco Fábio Ferreira de Lima; Diego R Mazzotti; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2015-07-23       Impact factor: 2.816

Review 2.  Sleep Disordered Breathing and the Pathogenesis of Atrial Fibrillation.

Authors:  Thomas Bitter; Dieter Horstkotte; Olaf Oldenburg
Journal:  J Atr Fibrillation       Date:  2013-06-30

3.  Severe obstructive sleep apnea increases mortality in patients with ischemic heart disease and myocardial injury.

Authors:  Christine H Won; Hyung J Chun; Suparna M Chandra; Priscilla S Sarinas; Rajinder K Chitkara; Paul A Heidenreich
Journal:  Sleep Breath       Date:  2013-03       Impact factor: 2.816

Review 4.  [Association of sleep-disordered breathing and malignant arrhythmias in patients with ischemic and dilated cardiomyopathy].

Authors:  Hazem Omran; Thomas Bitter; Henrik Fox; Dieter Horstkotte; Olaf Oldenburg
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-03-03

Review 5.  Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS).

Authors:  Alessandra Quercioli; François Mach; Fabrizio Montecucco
Journal:  Sleep Breath       Date:  2010-03-03       Impact factor: 2.816

6.  Analysis of systemic and airway inflammation in obstructive sleep apnea.

Authors:  Kensaku Aihara; Toru Oga; Yuichi Chihara; Yuka Harada; Kiminobu Tanizawa; Tomohiro Handa; Takefumi Hitomi; Kazuko Uno; Michiaki Mishima; Kazuo Chin
Journal:  Sleep Breath       Date:  2012-06-07       Impact factor: 2.816

7.  Association of serum hepcidin levels with the presence and severity of obstructive sleep apnea syndrome.

Authors:  Yu Liu; Zhengang Yu; Defeng Hua; Yan Chen; Shiliang Zheng; Leqiang Wang
Journal:  Med Sci Monit       Date:  2015-01-02

Review 8.  Obstructive Sleep Apnea: From Intermittent Hypoxia to Cardiovascular Complications via Blood Platelets.

Authors:  Agata Gabryelska; Zuzanna M Łukasik; Joanna S Makowska; Piotr Białasiewicz
Journal:  Front Neurol       Date:  2018-08-03       Impact factor: 4.003

9.  The role of obesity, different fat compartments and sleep apnea severity in circulating leptin levels: the Icelandic Sleep Apnea Cohort study.

Authors:  E S Arnardottir; G Maislin; N Jackson; R J Schwab; B Benediktsdottir; K Teff; S Juliusson; A I Pack; T Gislason
Journal:  Int J Obes (Lond)       Date:  2012-09-11       Impact factor: 5.095

10.  Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Carlos Zamarrón; Luis Valdés Cuadrado; Rodolfo Alvarez-Sala
Journal:  Pulm Med       Date:  2013-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.